Lifecore Biomedical, Inc. \De\

Ownership Transactions Reported by 26 Insiders

Symbol
LFCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3515 Lyman Boulevard, Chaska, MN

Insiders trading volume in the past year

Lifecore Biomedical, Inc. \De\ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher S. Kiper Director, 10%+ Owner $31.3M Jul 15, 2025
Wynnefield Partners Small Cap Value Lp I 10%+ Owner $19.3M Oct 3, 2024
Paul Josephs Chief Executive Officer, Director $5.19M +$97.6K +1.92% Jul 8, 2025
Thomas D. Salus Chief Legal & Administration $4.35M Jul 8, 2025
James Hall Chief Executive Officer, Director $4.25M Jun 1, 2023
Ryan Lake Chief Financial Officer $2.6M Sep 3, 2025
Aron R. English 10%+ Owner $1.88M -$9.87M -84% May 23, 2025
Albert D. Bolles Chief Executive Officer $1.64M May 23, 2022
Nelson Obus Director $965K Jul 15, 2025
John Morberg Chief Financial Officer $879K Jan 18, 2024
Katrina Houde Director $764K Jul 15, 2025
Joshua Schechter Director $748K Jul 15, 2025
Craig A. Barbarosh Director $617K Jul 8, 2024
Jeffrey L. Edwards Director $558K Jul 8, 2024
Raymond Diradoorian Director $490K Jul 8, 2024
Tonia L. Pankopf Director $417K Jun 4, 2022
Nathaniel Calloway Director $406K Jul 8, 2024
Catherine A. Sohn Director $378K Jun 4, 2022
Timothy P. Burgess Senior VP of Supply Chain $339K Jul 27, 2021
Humberto C. Antunes Director $328K Jul 15, 2025
Matthew Korenberg Director $308K Jul 15, 2025
Jason Aryeh Director $308K Jul 15, 2025
Paul H. Johnson Director $308K Jul 15, 2025
Deborah Carosella Director $256K Jun 4, 2022
Andrew Kenneth William Powell Director $192K Jun 4, 2022
Patrick D. Walsh Director $49.4K Jun 4, 2021

Recent Insider Transactions by Companies or Individuals for Lifecore Biomedical, Inc. \De\

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.